HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hemorheological and clinical efficiency of a new phospholipid hepatoprotective drug Phosphogliv in patients with psoriatic arthritis].

Abstract
A new phospholipid drug "Posphogliv" showed earlier good results in the treatment of liver discases. The mechanism of its effect consists in non-specific repair of biomembranes. In the present study it was used for the treatment of in patients with psoriatic arthritis, accompanied by severe damages of blood rheology. The group of patients took Phosphogliv 3 months in the dose of 0.6 g per day. Considerable decrease of erythrocytes aggregability was observed after the treatment. There were no changes in total blood viscosity. The clinical state of patients markedly improved after the treatment. Simultaneous decrease of blood C-reactive protein level suggests weakening of inflammation. The mechanism of these effects may involve direct influence of the phospholipid on erythrocyte membranes and/or with indirect influence through the improvement of liver function. The results show that Phosphogliv inclusion into therapy improved the state of patients with psoriatic arthritis. The results of the present study also indicate principal possibility of broadening of clinical use of this drug. Its positive effects are based on membrane reparative properties of polyunsaturated phosphatidylcholine in combination with anti-inflammatory and immunomodulative effects of its second component, glycyrrhizin acid.
AuthorsO M Ipatova, E L Nasonov, T V Korotaeva, N N Firsov, O A Ivkina, T I Torkhovskaia, A I Archakov
JournalBiomeditsinskaia khimiia (Biomed Khim) 2003 Sep-Oct Vol. 49 Issue 5 Pg. 484-90 ISSN: 2310-6972 [Print] Russia (Federation)
Vernacular TitleGemoreologicheskaia i klinicheskaia éffektivnost' novogo fosfolipidnogo gepatoprotektornogo preparata "Fosfogliv" u bol'nykh psoriaticheskim artritom.
PMID16119102 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • Phosphatidylcholines
  • Phosphogliv
  • Glycyrrhizic Acid
Topics
  • Arthritis, Psoriatic (blood, drug therapy)
  • Blood Viscosity (drug effects)
  • Drug Combinations
  • Erythrocyte Aggregation (drug effects)
  • Glycyrrhizic Acid (administration & dosage, therapeutic use)
  • Hemorheology
  • Humans
  • Phosphatidylcholines (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: